Diffusion-weighted imaging of the breast: Principles and clinical applications

Radiographics

Volumn 31, Issue 4, 2011, Pages 1059-1084

  Woodhams, Reiko ^a   Ramadan, Saadallah ^b   Stanwell, Peter ^c   Sakamoto, Satoko ^a   Hata, Hirofumi ^a   Ozaki, Masanori ^a   Kan, Shinichi ^a   Inoue, Yusuke ^a  

^a KITASATO UNIVERSITY HOSPITAL   (Japan)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST; BREAST DISEASE; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; IMAGE ENHANCEMENT; METHODOLOGY; PATHOLOGY;

BREAST; BREAST DISEASES; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE ENHANCEMENT;

EID: 79960535225     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.314105160     Document Type: Article

References (78)

1. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007;188(6):1622-1635.
2. Englander SA, Ulug AM, Brem R, Glickson JD, van Zijl PC. Diffusion imaging of human breast. NMR Biomed 1997;10(7):348-352.
3. Kuroki Y, Nasu K, Kuroki S, et al. Diffusionweighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value. Magn Reson Med Sci 2004; 3(2):79-85.
4. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002;16(2):172-178.
5. Woodhams R, Matsunaga K, Kan S, et al. ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 2005;4(1):35-42.
6. Woodhams R, Matsunaga K, Iwabuchi K, et al. Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 2005;29(5): 644-649.
7. Rubesova E, Grell AS, De Maertelaer V, Metens T, Chao SL, Lemort M. Quantitative diffusion imaging in breast cancer: a clinical prospective study. J Magn Reson Imaging 2006;24(2):319-324.
8. Marini C, Iacconi C, Giannelli M, Cilotti A, Moretti M, Bartolozzi C. Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol 2007;17(10):2646-2655.
9. Kuroki Y, Nasu K. Advances in breast MRI: diffusion- weighted imaging of the breast. Breast Cancer 2008;15(3):212-217.
10. Woodhams R, Kakita S, Hata H, et al. Diffusionweighted imaging of mucinous carcinoma of the breast: evaluation of apparent diffusion coefficient and signal intensity in correlation with histologic findings. AJR Am J Roentgenol 2009;193(1): 260-266.
11. American College of Radiology. BI-RADS atlas. Reston, Va: American College of Radiology, 2003.
12. Gilles R, Guinebretière JM, Lucidarme O, et al. Nonpalpable breast tumors: diagnosis with contrastenhanced subtraction dynamic MR imaging. Radiology 1994;191(3):625-631.
13. Boetes C, Strijk SP, Holland R, Barentsz JO, Van Der Sluis RF, Ruijs JH. False-negative MR imaging of malignant breast tumors. Eur Radiol 1997;7(8): 1231-1234.
14. Ghai S, Muradali D, Bukhanov K, Kulkarni S. Nonenhancing breast malignancies on MRI: sonographic and pathologic correlation. AJR Am J Roentgenol 2005;185(2):481-487.
15. Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Garrido L. Breast cancer: regional blood flow and blood volume measured with magnetic susceptibility-based MR imaging-initial results. Radiology 2002;223 (2):558-565.
16. Baron P, Dorrius MD, Kappert P, Oudkerk M, Sijens PE. Diffusion-weighted imaging of normal fibroglandular breast tissue: influence of microperfusion and fat suppression technique on the apparent diffusion coefficient. NMR Biomed 2010;23(4): 399-405.
17. Jin G, An N, Jacobs MA, Li K. The role of parallel diffusion-weighted imaging and apparent diffusion coefficient (ADC) map values for evaluating breast lesions: preliminary results. Acad Radiol 2010;17(4): 456-463.
18. Matsuki M, Inada Y, Nakai G, et al. Diffusionweighted MR imaging of pancreatic carcinoma. Abdom Imaging 2007;32(4):481-483.
19. Mazaheri Y, Shukla-Dave A, Hricak H, et al. Prostate cancer: identification with combined diffusionweighted MR imaging and 3D 1H MR spectroscopic imaging-correlation with pathologic findings. Radiology 2008;246(2):480-488.
20. Nasu K, Kuroki Y, Nawano S, et al. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 2006;239 (1):122-130.
21. Raya JG, Dietrich O, Reiser MF, Baur-Melnyk A. Methods and applications of diffusion imaging of vertebral bone marrow. J Magn Reson Imaging 2006;24(6):1207-1220.
22. Sugita R, Ito K, Fujita N, Takahashi S. Diffusionweighted MRI in abdominal oncology: clinical applications. World J Gastroenterol 2010;16(7): 832-836.
23. Yoshikawa T, Ohno Y, Kawamitsu H, et al. Abdominal apparent diffusion coefficient measurements: effect of diffusion-weighted image quality and usefulness of anisotropic images. Magn Reson Imaging 2008;26(10):1415-1420.
24. Hatakenaka M, Soeda H, Yabuuchi H, et al. Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci 2008;7(1):23-29.
25. Kim SH, Cha ES, Kim HS, et al. Diffusionweighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors. J Magn Reson Imaging 2009;30(3): 615-620.
26. Kinoshita T, Yashiro N, Ihara N, Funatu H, Fukuma E, Narita M. Diffusion-weighted half-Fourier singleshot turbo spin echo imaging in breast tumors: differentiation of invasive ductal carcinoma from fibroadenoma. J Comput Assist Tomogr 2002;26(6): 1042-1046.
27. Kuroki-Suzuki S, Kuroki Y, Nasu K, Nawano S, Moriyama N, Okazaki M. Detecting breast cancer with non-contrast MR imaging: combining diffusionweighted and STIR imaging. Magn Reson Med Sci 2007;6(1):21-27.
28. Park MJ, Cha ES, Kang BJ, Ihn YK, Baik JH. The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J Radiol 2007;8(5):390-396.
29. Sinha S, Lucas-Quesada FA, Sinha U, DeBruhl N, Bassett LW. In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging 2002;15(6):693-704.
30. Baltzer PA, Benndorf M, Dietzel M, Gajda M, Camara O, Kaiser WA. Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesions. Eur Radiol 2010;20(5): 1101-1110.
31. Wenkel E, Geppert C, Schulz-Wendtland R, et al. Diffusion weighted imaging in breast MRI: comparison of two different pulse sequences. Acad Radiol 2007;14(9):1077-1083.
32. Kazama T, Nasu K, Kuroki Y, Nawano S, Ito H. Comparison of diffusion-weighted images using short inversion time inversion recovery or chemical shift selective pulse as fat suppression in patients with breast cancer. Jpn J Radiol 2009;27(4):163-167.
33. Heidemann RM, Ozsarlak O, Parizel PM, et al. A brief review of parallel magnetic resonance imaging. Eur Radiol 2003;13(10):2323-2337.
34. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn Reson Med 1999;42(5):952-962.
35. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986; 161(2):401-407.
36. Bammer R. Basic principles of diffusion-weighted imaging. Eur J Radiol 2003;45(3):169-184.
37. Tozaki M, Fukuma E. 1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy? AJR Am J Roentgenol 2009;193(3):840-849.
38. Woodhams R, Kakita S, Hata H, et al. Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging-comparison with contrast-enhanced MR imaging and pathologic findings. Radiology 2010;254(2):357-366.
39. Toyoda K, Kitai S, Ida M, Suga S, Aoyagi Y, Fukuda K. Usefulness of high-b-value diffusion-weighted imaging in acute cerebral infarction. Eur Radiol 2007;17(5):1212-1220.
40. Seo HS, Chang KH, Na DG, Kwon BJ, Lee DH. High b-value diffusion (b = 3000 s/mm2) MR imaging in cerebral gliomas at 3T: visual and quantitative comparisons with b = 1000 s/mm2. AJNR Am J Neuroradiol 2008;29(3):458-463.
41. Pereira FP, Martins G, Figueiredo E, et al. Assessment of breast lesions with diffusion-weighted MRI: comparing the use of different b values. AJR Am J Roentgenol 2009;193(4):1030-1035.
42. Mulkern RV, Gudbjartsson H, Westin CF, et al. Multi-component apparent diffusion coefficients in human brain. NMR Biomed 1999;12(1):51-62.
43. Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 1999; 210(3):617-623.
44. Moore RJ, Issa B, Tokarczuk P, et al. In vivo intravoxel incoherent motion measurements in the human placenta using echo-planar imaging at 0.5 T. Magn Reson Med 2000;43(2):295-302.
45. Yeung DK, Wong SY, Griffith JF, Lau EM. Bone marrow diffusion in osteoporosis: evaluation with quantitative MR diffusion imaging. J Magn Reson Imaging 2004;19(2):222-228.
46. Mulkern RV, Barnes AS, Haker SJ, et al. Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. Magn Reson Imaging 2006;24(5):563-568.
47. Yoshikawa MI, Ohsumi S, Sugata S, et al. Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med 2008;26(4):222-226.
48. Yankeelov TE, Lepage M, Chakravarthy A, et al. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 2007;25(1):1-13.
49. Yabuuchi H, Matsuo Y, Okafuji T, et al. Enhanced mass on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. J Magn Reson Imaging 2008;28(5):1157-1165.
50. Partridge SC, Mullins CD, Kurland BF, et al. Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size. AJR Am J Roentgenol 2010;194 (6):1664-1673.
51. Ei Khouli RH, Jacobs MA, Mezban SD, et al. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. Radiology 2010;256(1):64-73.
52. Poon CS, Bronskill MJ, Henkelman RM, Boyd NF. Quantitative magnetic resonance imaging parameters and their relationship to mammographic pattern. J Natl Cancer Inst 1992;84(10):777-781.
53. Partridge SC, McKinnon GC, Henry RG, Hylton NM. Menstrual cycle variation of apparent diffusion coefficients measured in the normal breast using MRI. J Magn Reson Imaging 2001;14(4):433-438.
54. Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Garrido L. Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue. Breast J 2005;11(4): 236-241.
55. Stadlbauer A, Bernt R, Gruber S, et al. Diffusionweighted MR imaging with background body signal suppression (DWIBS) for the diagnosis of malignant and benign breast lesions. Eur Radiol 2009;19(10): 2349-2356.
56. Atlas SW, DuBois P, Singer MB, Lu D. Diffusion measurements in intracranial hematomas: implications for MR imaging of acute stroke. AJNR Am J Neuroradiol 2000;21(7):1190-1194.
57. Fischbein NJ, Roberts TP, Dillon WP. Bleed or stroke? diffusion measurements in intracranial hematomas. AJNR Am J Neuroradiol 2000;21(7): 1179-1180.
58. Yamada K, Kubota H, Kizu O, et al. Effect of intravenous gadolinium-DTPA on diffusion-weighted images: evaluation of normal brain and infarcts. Stroke 2002;33(7):1799-1802.
59. Chen G, Jespersen SN, Pedersen M, Pang Q, Horsman MR, Stødkilde-Jørgensen H. Intravenous administration of Gd-DTPA prior to DWI does not affect the apparent diffusion constant. Magn Reson Imaging 2005;23(5):685-689.
60. Chiu FY, Jao JC, Chen CY, et al. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions. J Comput Assist Tomogr 2005;29(2): 176-180.
61. Firat AK, Sanli B, Karakas HM, Erdem G. The effect of intravenous gadolinium-DTPA on diffusionweighted imaging. Neuroradiology 2006;48(7): 465-470.
62. Yuen S, Yamada K, Goto M, Nishida K, Takahata A, Nishimura T. Microperfusion-induced elevation of ADC is suppressed after contrast in breast carcinoma. J Magn Reson Imaging 2009;29(5):1080-1084.
63. Ramadan S, Mulkern RV. Comment on ADC reductions in postcontrast breast tumors. J Magn Reson Imaging 2010;31(1):262; author reply 263-264.
64. Manton DJ, Chaturvedi A, Hubbard A, et al. Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. Br J Cancer 2006;94(3):427-435.
65. Pickles MD, Gibbs P, Lowry M, Turnbull LW. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 2006;24(7):843-847.
66. Sharma U, Danishad KK, Seenu V, Jagannathan NR. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed 2009;22(1):104-113.
67. Galons JP, Altbach MI, Paine-Murrieta GD, Taylor CW, Gillies RJ. Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia 1999;1(2):113-117.
68. Lee KC, Moffat BA, Schott AF, et al. Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy. Clin Cancer Res 2007; 13(2 pt 1):443-450.
69. Esserman L, Kaplan E, Partridge S, et al. MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol 2001;8 (6):549-559.
70. Rieber A, Brambs HJ, Gabelmann A, Heilmann V, Kreienberg R, Kühn T. Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 2002;12(7):1711-1719.
71. Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004;233(3): 830-849.
72. Schott AF, Roubidoux MA, Helvie MA, et al. Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005;92(3): 231-238.
73. Nakamura S, Ishiyama M, Tsunoda-Shimizu H. Magnetic resonance mammography has limited ability to estimate pathological complete remission after primary chemotherapy or radiofrequency ablation therapy. Breast Cancer 2007;14(2):123-130.
74. Chen JH, Feig B, Agrawal G, et al. MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer 2008;112(1):17-26.
75. Kuhl CK, Gieseke J, von Falkenhausen M, et al. Sensitivity encoding for diffusion-weighted MR imaging at 3.0 T: intraindividual comparative study. Radiology 2005;234(2):517-526.
76. Matsuoka A, Minato M, Harada M, et al. Comparison of 3.0- and 1.5-tesla diffusion-weighted imaging in the visibility of breast cancer. Radiat Med 2008; 26(1):15-20.
77. Lo GG, Ai V, Chan JK, et al. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T. J Comput Assist Tomogr 2009;33 (1):63-69.
78. Belli P, Costantini M, Bufi E, Magistrelli A, La Torre G, Bonomo L. Diffusion-weighted imaging in breast lesion evaluation. Radiol Med (Torino) 2010; 115(1):51-69.